{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T07:50:36Z","timestamp":1718265036912},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,2]]},"DOI":"10.7759\/cureus.41285","type":"journal-article","created":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T19:50:16Z","timestamp":1688327416000},"source":"Crossref","is-referenced-by-count":1,"title":["p16 Immunohistochemical Expression in Nephrogenic Adenoma"],"prefix":"10.7759","author":[{"given":"Juan Carlos","family":"Alvarez Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz A","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasily","family":"Ovechko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Eyzaguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.889441","article-title":"Nephrogenic adenoma of the urinary bladder: a report of three cases and a review of the literature","volume":"19","author":"Kuzaka B","year":"2014","unstructured":"Kuzaka B, Pude\u0142ko P, Powa\u0142a A, G\u00f3rnicka B, Radziszewski P. Nephrogenic adenoma of the urinary bladder: a report of three cases and a review of the literature. Ann Transplant. 2014, 19:153-6. 10.12659\/AOT.889441","journal-title":"Ann Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/704982","article-title":"Nephrogenic adenoma of the urinary bladder: a review of the literature","volume":"2015","author":"Venyo AK","year":"2015","unstructured":"Venyo AK. Nephrogenic adenoma of the urinary bladder: a review of the literature. Int Sch Res Notices. 2015, 2015:704982. 10.1155\/2015\/704982","journal-title":"Int Sch Res Notices"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1985.tb06303.x","article-title":"Adenomatous metaplasia (nephrogenic adenoma) of urothelium. An analysis of 70 cases","volume":"57","author":"Ford TF","year":"1985","unstructured":"Ford TF, Watson GM, Cameron KM. Adenomatous metaplasia (nephrogenic adenoma) of urothelium. An analysis of 70 cases. Br J Urol. 1985, 57:427-33. 10.1111\/j.1464-410x.1985.tb06303.x","journal-title":"Br J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1242\/dev.116.3.611","article-title":"PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors","volume":"116","author":"Poleev A","year":"1992","unstructured":"Poleev A, Fickenscher H, Mundlos S, et al.. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development. 1992, 116:611-23. 10.1242\/dev.116.3.611","journal-title":"Development"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.12.021","article-title":"Practical issues in the application of p16 immunohistochemistry in diagnostic pathology","volume":"51","author":"Mahajan A","year":"2016","unstructured":"Mahajan A. Practical issues in the application of p16 immunohistochemistry in diagnostic pathology. Hum Pathol. 2016, 51:64-74. 10.1016\/j.humpath.2015.12.021","journal-title":"Hum Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205216","article-title":"p16","volume":"71","author":"Serra S","year":"2018","unstructured":"Serra S, Chetty R. p16. J Clin Pathol. 2018, 71:853-8. 10.1136\/jclinpath-2018-205216","journal-title":"J Clin Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009933108","article-title":"Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming","volume":"108","author":"McLaughlin-Drubin ME","year":"2011","unstructured":"McLaughlin-Drubin ME, Crum CP, M\u00fcnger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A. 2011, 108:2130-5. 10.1073\/pnas.1009933108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0801","article-title":"Intrinsic cooperation between p16INK4a and p21Waf1\/Cip1 in the onset of cellular senescence and tumor suppression in vivo","volume":"70","author":"Takeuchi S","year":"2010","unstructured":"Takeuchi S, Takahashi A, Motoi N, et al.. Intrinsic cooperation between p16INK4a and p21Waf1\/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res. 2010, 70:9381-90. 10.1158\/0008-5472.CAN-10-0801","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.02.012","article-title":"Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia","volume":"35","author":"Tringler B","year":"2004","unstructured":"Tringler B, Gup CJ, Singh M, Groshong S, Shroyer AL, Heinz DE, Shroyer KR. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol. 2004, 35:689-96. 10.1016\/j.humpath.2004.02.012","journal-title":"Hum Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.542","article-title":"Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx","volume":"106","author":"Junor E","year":"2012","unstructured":"Junor E, Kerr G, Oniscu A, Campbell S, Kouzeli I, Gourley C, Cuschieri K. Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx. Br J Cancer. 2012, 106:358-65. 10.1038\/bjc.2011.542","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.11.017","article-title":"Human papillomavirus (HPV) in head and neck cancer","volume":"32 Suppl 1","author":"Syrj\u00e4nen S","year":"2005","unstructured":"Syrj\u00e4nen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005, 32 Suppl 1:S59-66. 10.1016\/j.jcv.2004.11.017","journal-title":"J Clin Virol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano T","year":"1998","unstructured":"Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998, 153:1741-8. 10.1016\/S0002-9440(10)65689-1","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1997.00418.x","article-title":"Nephrogenic adenoma--a study with special reference to clinical presentation","volume":"80","author":"Peeker R","year":"1997","unstructured":"Peeker R, Aldenborg F, Fall M. Nephrogenic adenoma--a study with special reference to clinical presentation. Br J Urol. 1997, 80:539-42. 10.1046\/j.1464-410x.1997.00418.x","journal-title":"Br J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.266065126","article-title":"From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation","volume":"26","author":"Wong-You-Cheong JJ","year":"2006","unstructured":"Wong-You-Cheong JJ, Woodward PJ, Manning MA, Davis CJ. From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation. Radiographics. 2006, 26:1847-68. 10.1148\/rg.266065126","journal-title":"Radiographics"},{"key":"ref15","article-title":"Nephrogenic adenoma","author":"Epstein JI","year":"2004","unstructured":"Epstein JI, Amin MB, Reuter VE. Nephrogenic adenoma. Bladder Biopsy Interpretation. Epstein JI, Amin MB, Reuter VE (ed): Lippincott Williams &amp; Wilkins, Philadelphia, PA; 2004. 171-76."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2012.05.003","article-title":"Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas","volume":"17","author":"Quinones W","year":"2013","unstructured":"Quinones W, Ziober A, Yao Y, Bing Z. Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas. Ann Diagn Pathol. 2013, 17:41-4. 10.1016\/j.anndiagpath.2012.05.003","journal-title":"Ann Diagn Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.06.005","article-title":"Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases","volume":"92","author":"Zannoni GF","year":"2019","unstructured":"Zannoni GF, Santoro A, Angelico G, et al.. Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases. Hum Pathol. 2019, 92:10-7. 10.1016\/j.humpath.2019.06.005","journal-title":"Hum Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas DA","year":"2020","unstructured":"Barocas DA, Boorjian SA, Alvarez RD, et al.. Microhematuria: AUA\/SUFU guideline. J Urol. 2020, 204:778-86. 10.1097\/JU.0000000000001297","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.06.028","article-title":"Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy","volume":"56","author":"van Rhijn BW","year":"2009","unstructured":"van Rhijn BW, Burger M, Lotan Y, et al.. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009, 56:430-42. 10.1016\/j.eururo.2009.06.028","journal-title":"Eur Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma In situ) - 2019 update","volume":"76","author":"Babjuk M","year":"2019","unstructured":"Babjuk M, Burger M, Comp\u00e9rat EM, et al.. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma In situ) - 2019 update. Eur Urol. 2019, 76:639-57. 10.1016\/j.eururo.2019.08.016","journal-title":"Eur Urol"},{"key":"ref21","article-title":"Invasive urothelial carcinoma","year":"2022","unstructured":"Invasive urothelial carcinoma. WHO Classification of Tumours, 5th Edition. Urinary and Male Genital Tumours. International Agency for Research in Cancer, Lyon, France; 2022. 150."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/his.13752","article-title":"Variants and new entities of bladder cancer","volume":"74","author":"Lopez-Beltran A","year":"2019","unstructured":"Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L. Variants and new entities of bladder cancer. Histopathology. 2019, 74:77-96. 10.1111\/his.13752","journal-title":"Histopathology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin MB","year":"2014","unstructured":"Amin MB, Trpkov K, Lopez-Beltran A, Grignon D. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014, 38:e20-34. 10.1097\/PAS.0000000000000240","journal-title":"Am J Surg Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000238","article-title":"Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Epstein JI","year":"2014","unstructured":"Epstein JI, Egevad L, Humphrey PA, Montironi R. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014, 38:e6-e19. 10.1097\/PAS.0000000000000238","journal-title":"Am J Surg Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s42047-019-0030-2","article-title":"Prognostic significance of p16 immunohistochemical expression in urothelial carcinoma","volume":"2","author":"Hashmi AA","year":"2019","unstructured":"Hashmi AA, Hussain ZF, Irfan M, et al.. Prognostic significance of p16 immunohistochemical expression in urothelial carcinoma. Surg Exp Pathol. 2019, 2:3. 10.1186\/s42047-019-0030-2","journal-title":"Surg Exp Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-020-01273-5","article-title":"The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages","volume":"31","author":"Knipper S","year":"2020","unstructured":"Knipper S, Pecoraro A, Palumbo C, et al.. The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages. Cancer Causes Control. 2020, 31:283-90. 10.1007\/s10552-020-01273-5","journal-title":"Cancer Causes Control"},{"key":"ref27","article-title":"Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies","volume":"52","author":"Summerton N","year":"2002","unstructured":"Summerton N, Mann S, Rigby AS, Ashley J, Palmer S, Hetherington JW. Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies. Br J Gen Pract. 2002, 52:284-9.","journal-title":"Br J Gen Pract"},{"key":"ref28","article-title":"Prostatic acinar adenocarcinoma","year":"2022","unstructured":"Prostatic acinar adenocarcinoma. WHO Classification of Tumours, 5th Edition. Urinary and Male Genital Tumours. Internaltional Agency for Research in Cancer, Lyon, France; 2022. 203."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.03.55","article-title":"Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study","volume":"8","author":"Huang JF","year":"2020","unstructured":"Huang JF, Shen J, Li X, et al.. Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med. 2020, 8:482. 10.21037\/atm.2020.03.55","journal-title":"Ann Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.01.002","article-title":"Macroscopic features of prostate cancer","volume":"50","author":"Lindh C","year":"2018","unstructured":"Lindh C, Delahunt B, Egevad L. Macroscopic features of prostate cancer. Pathology. 2018, 50:382-8. 10.1016\/j.pathol.2018.01.002","journal-title":"Pathology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.08.012","article-title":"Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy","volume":"80","author":"Iremashvili V","year":"2012","unstructured":"Iremashvili V, Pelaez L, Jord\u00e1 M, Manoharan M, Rosenberg DL, Soloway MS. Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy. Urology. 2012, 80:1063-9. 10.1016\/j.urology.2012.08.012","journal-title":"Urology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.036442","article-title":"Diagnosis of adenocarcinoma in prostate needle biopsy tissue","volume":"60","author":"Humphrey PA","year":"2007","unstructured":"Humphrey PA. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol. 2007, 60:35-42. 10.1136\/jcp.2005.036442","journal-title":"J Clin Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.139","article-title":"Prostate cancer: diagnostic criteria and role of immunohistochemistry","volume":"31","author":"Magi-Galluzzi C","year":"2018","unstructured":"Magi-Galluzzi C. Prostate cancer: diagnostic criteria and role of immunohistochemistry. Mod Pathol. 2018, 31:S12-21. 10.1038\/modpathol.2017.139","journal-title":"Mod Pathol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12997","article-title":"Prognostic significance of p16 expression in high-grade prostate adenocarcinoma","volume":"70","author":"Takahara T","year":"2020","unstructured":"Takahara T, Satou A, Sugie M, Watanabe M, Kanao K, Sumitomo M, Tsuzuki T. Prognostic significance of p16 expression in high-grade prostate adenocarcinoma. Pathol Int. 2020, 70:743-51. 10.1111\/pin.12997","journal-title":"Pathol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159695-p16-immunohistochemical-expression-in-nephrogenic-adenoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:30Z","timestamp":1707508890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159695-p16-immunohistochemical-expression-in-nephrogenic-adenoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,2]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.41285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,2]]}}}